| Financial Year |
March 31 2023 |
| Monetary Funds |
243,273,036.63 |
| Held-for-trading Financial Assets |
166,035,415.22 |
| Notes Receivable |
20,609,419.13 |
| Accounts Receivable |
234,711,686.42 |
| Advances to Suppliers |
90,670,339.92 |
| Other Receivables |
550,020.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
368,423,115.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,670,813.99 |
| Total Current Assets |
1,212,309,324.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
228,424,878.55 |
| Under-construction Projects |
262,204,148.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
85,715,679.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
170,523.90 |
| Deferred Income Tax Assets |
5,669,949.29 |
| Other Non-Current Assets |
231,318,571.17 |
| Sub-Total of Non-Current Assets |
816,255,609.83 |
| Total Assets |
2,028,564,933.96 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
179,035,403.09 |
| Accounts Payable |
59,561,918.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,957,141.43 |
| Taxes Payable |
8,928,671.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
119,706,846.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,472.67 |
| Other Current Liabilities |
2,228,549.44 |
| Sub-Total of Current Liabilities |
401,778,709.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
40,679,110.89 |
| Total Liabilities |
442,457,819.91 |
| Paid-In Capital(Or Share Stock) |
208,880,000.00 |
| Capital Surplus |
551,843,472.25 |
| Surplus Reserve |
89,642,344.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
735,741,297.58 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,586,107,114.05 |
| Owner's Equity（Stockholder's Equity） |
1,586,107,114.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,028,564,933.96 |
